What Are The Barriers to HCV Treatment?

Video

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.

Recent Videos
Related Content
Israel’s Hepatitis C Elimination Program is Making Strides

Israel’s Hepatitis C Elimination Program is Making Strides

John Parkinson
November 21st 2024
Article
From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

From Pathogen to Infectious Disease Diagnosis: Taking on Potential Standard-of-Care Diagnostic Opportunities

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
August 1st 2024
Podcast
Investigational Combination Hepatitis C Therapy Demonstrates a 97% Sustained Virologic Response

Investigational Combination Hepatitis C Therapy Demonstrates a 97% Sustained Virologic Response

John Parkinson
November 19th 2024
Article
From Pathogen to Infectious Disease Diagnosis

From Pathogen to Infectious Disease Diagnosis

Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc
July 12th 2024
Podcast
Study Finds Association Between Illicit Fentanyl Use and Increased Risk of Hepatitis C

Study Finds Association Between Illicit Fentanyl Use and Increased Risk of Hepatitis C

Sophia Abene
November 14th 2024
Article
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C

Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C

Sophia Abene
November 13th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.